Senate ends debate on FDA reauthorization bill

The vote was 89-3 on the motion to end debate on the Food and Drug Administration Safety and Innovation ACt (S. 3187).

A week earlier the House approved the bill and sent the amended version back to the Senate.

The legislation reauthorizes certain FDA programs and expands a user-fee program in order to speed up the FDA's approval process for certain drug and medical device applications.

Sens. Richard Burr (R-N.C.), Rand Paul (R-Ky.) and Bernie Sanders (I-Vt.) voted against the motion to end debate.

More in Transportation

Senate appoints negotiators for highway bill talks

Read more »